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receptor protein was confirmed at the same sites. In
conclusion, we have demonstrated the up-regulation
of the pancreatic acinar cell kinin-B1 receptors during
ischaemia/reperfusion. The novel functional finding
was that antagonism of the kinin-B1 receptors de-
creased the survival rate in an experimental model of
pancreatitis. 
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Introduction
Evidence for the enhanced formation and release of kinin
peptides in acute pancreatitis is well established (Gries-
bacher et al., 1993; Hoffmann et al., 1997). The kinin pep-
tides are potent mediators of vasodilation, increased
capillary permeability, oedema and pain (Bhoola et al.,
1992). Furthermore, mild pancreatitis can be increased in
severity by the continuous, intra-arterial infusion of
bradykinin (Hoffmann et al., 1996a).
In mammals, the cellular actions of kinins are trans-
ducted by two receptors, the kinin-B1 receptor and kinin-
B2 receptor. Whereas the kinin-B2 receptor is constitu-
tively expressed, the kinin-B1 receptor is induced by a
variety of stimuli. Isolated large arterial preparations
respond to the kinin-B1 receptor agonist, des-Arg9-
bradykinin (Regoli et al., 1977). Expression of kinin-B1 re-
ceptors is also increased by the infusion of bradykinin or
by the inhibition of angiotensin-converting enzyme, kini-
nase II (Nwator et al., 1989), probably as a positive feed-
back mechanism following the maximal activation of the
kinin-B1 receptors expressed under normal conditions.
Induction of kinin-B1 receptors is enhanced in inflamed
organs, as has been observed in renal transplant rejec-
tion and parenchymal diseases (Bhoola et al., 2001). Ad-
ditionally, ischaemia/reperfusion of the myocardium and
endotoxin infusion subjected to piglets enhances the ex-
pression of kinin-B1 receptors (Schremmer-Danninger
et al., 1998; Mazenot et al., 2001).
During ischaemia/reperfusion studies in experimental
pancreatitis, antagonism of the kinin-B2 receptors has
been shown to exhibit a protective effect (Closa et al.,
1995; Hoffmann et al., 1996b,c, 1997; Kanbe et al., 1996).
The question whether kinin-B1 receptors serve a func-
tionally important role in pancreatitis has not been investi-
gated. Therefore, one purpose of our study was to assess
both the influence of a kinin-B1 receptor antagonist (CP
0298) alone, and in combination with a kinin-B2 receptor
antagonist (CP 0597), by observing the microcirculation in
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In this study we compare the role of kinin-B1 and B2
receptors during ischaemia/reperfusion of rat pan-
creas. Our investigations were prompted by the ob-
servation that infusion of a kinin-B2 receptor antago-
nist produced significant improvement in acute
experimental pancreatitis. In an acute model with two
hours of ischaemia/two hours of reperfusion, applica-
tion of the kinin-B1 receptor antagonist (CP-0298)
alone, or in combination with kinin-B2 receptor antag-
onist (CP-0597), significantly reduced the number of
adherent leukocytes in post-capillary venules. In a
chronic model with five days of reperfusion, the con-
tinuous application of kinin-B1 receptor antagonist or
a combination of kinin-B1 and B2 receptor antago-
nists markedly reduced the survival rate. In kinin-re-
ceptor binding studies kinin-B1 receptor showed a
22-fold increase in expression during the time of is-
chaemia/reperfusion. Carboxypeptidase M activity
was up-regulated 10-fold following two hours of is-
chaemia and two hours of reperfusion, provided the
appropriate specific ligand, des-Arg10-kallidin and/or
des-Arg9-bradykinin, was used. The occurrence of
kinin-B1 receptor binding sites on acinar cell mem-
branes was demonstrated by micro-autoradiography.
With a specific antibody, the localisation of kinin-B1
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an acute model, and mortality in a chronic model of pan-
creatitis. The second aim of our study was to localise and
quantify the kinin-B1 receptor, and to determine the enzy-
matic activity of carboxypeptidase M activity, providing
the kinin-B1 receptor ligand in the acute model.
Results
Acute Model
Survival All sham-operated animals survived the ob-
servation period of 2.5 h. One animal of the ischaemia/
reperfusion control group, 6 animals of the kinin-B1 re-
ceptor antagonist group, and 4 rats of the combined
kinin-B1 and B2 receptor antagonists group, died within
the reperfusion period of 2.5 h, but after the registered
observation time of 120 min. n=7 in each group. 
Blood Gases During the experiment pCO2 and pO2
were kept constant in all groups. The pH decreased
slightly from a mean of 7.39±0.02 at the beginning of the
experiment to 7.35±0.02 at the end. In all four groups the
base excess decreased continuously from a baseline of
– 1.54±0.71 mM to – 5.63±0.96 mM after 2 h of reperfu-
sion. Within these parameters no significant difference
was observed at the equivalent time-points between the
groups.
Macro-Haemodynamic Parameters In sham-operat-
ed animals the mean arterial pressure (MAP) showed no
major changes during the time of experiment. All groups
made ischaemic showed a significant drop in blood pres-
sure after the onset of reperfusion (Figure 1A). In the sham
group, the central venous pressure (CVP) remained almost
stable during the experimental period. In groups 3 and 4
(involving kinin antagonists) there was a continuous de-
crease of CVP during the observed reperfusion period. At
30 min of reperfusion, the ischaemia/reperfusion control
group showed a significant fall in CVP compared to the an-
tagonism groups, which remained at that level during the
time of the experiment (Figure 1B). The heart rate (HR) did
not significantly change between the groups (not shown).
Haematocrit At the beginning of each experiment the
haematocrit of all groups was 41±2.1%. There was no
appreciable change of haematocrit after the time of is-
chaemia. At 30 min of reperfusion, the haematocrit of the
ischaemia/reperfusion control group without treatment
with antagonists (group 2), when compared to the other
groups, was significantly elevated to a mean value of
48.3±2.63%. At 60 min and 120 min of reperfusion, the
haematocrit of the antagonist-treated groups 3 and 4
was also increased. Only the haematocrit of the sham
group (group 1) remained virtually unchanged, and at
these time-points was significantly lower than the
haematocrit of all the other groups (Figure 2A).
The peripheral leukocyte count decreased slightly in all
groups (basal 9.3±2.3 leukocytes/mm2, at the end
6.6±1.4 leukocytes/mm2), with no significant difference
between the groups (not shown).
Micro-Haemodynamic Parameters In all groups with
experimentally-induced ischaemia, the functional capil-
lary density (FCD) was significantly reduced compared to
the sham group (Figure 2B). During the reperfusion peri-
od, the number of perfused capillaries decreased further,
widening the gap relevant to the sham group. Between
antagonist-treated groups 3 and 4, and not antagonist-
treated group 2, as well as between the two antagonist-
treated groups, there was no significant difference at any
of the observation time-points.
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Fig. 1 Acute Model: Mean Arterial Pressure and Central Ve-
nous Pressure.
n=7 in each group; group 1: sham-operated, group 2: is-
chaemia/reperfusion control, group 3: kinin-B1 receptor antago-
nist, group 4: kinin-B1 and B2 receptor antagonists. Time points
show values at the end of preparation, end of ischaemia (2 h), af-
ter 30 min, 60 min and 120 min of reperfusion; values represent
means ± SEM. *p<0.05 vs. ischaemia/reperfusion control, kinin-
B1 receptor antagonist and kinin-B1 and -B2 receptor antago-
nists (Student-Newman-Keul test). For details see Materials and
Methods.
(A) Changes of mean arterial pressure (MAP). Animals of all
groups made ischaemic showed a significant drop in blood
pressure after onset of reperfusion. (B) Changes of central ve-
nous pressure (CVP). Rats of antagonist-treated groups 3 and 4
showed a continuous fall, group 2 showed a significant drop af-
ter the onset of reperfusion.
**p<0.05 vs. ischaemia/reperfusion control and kinin-B1 recep-
tor antagonist (Student-Newman-Keul test).
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The fraction of rolling leukocytes did not significantly
differ among all of the groups (29.4±4.7 cells/mm2 at
30 min, 31.0±5.5 cells/mm2 at 120 min). The number of
adherent leukocytes (stickers) stayed constant in the
sham group (Figure 2C). However, the ischaemia control
group showed a substantial increase of so-called stick-
ers during the period of observation: Until 30 min, the
amount of stickers remained the same as for the sham
group, whereas at 60 and 120 min after onset of is-
chaemia the number was significantly greater than that of
the other groups (Figure 2C). In the antagonist-treated
animals of groups 3 and 4, the accumulation of leuko-
cytes at 30 min was nearly the same as in sham-operat-
ed rats, but at 60 and 120 min significantly higher. There
were no significant differences between the two antago-
nist-treated groups (Figure 2C).
Morphology Histology of pancreatic tissue revealed
no apparent sign of tissue damage or inflammatory
process in biopsies obtained from sham-operated ani-
mals. The pancreatic tissue harvested from all animals
subjected to ischaemia and reperfusion, regardless of
treatment, showed areas with distinct oedema, necrotic
areas and signs of inflammation.
Chronic Model
In the sham group (group I) all rats survived the observa-
tion period of 5 days. In the ischaemia/reperfusion group
(group II), four of the six animals survived, resulting in a
survival rate of 67%. None of the animals receiving the
kinin-B1 receptor antagonist (group III) survived, and in
the kinin-B1 and B2 receptor antagonism group (group
IV) only one rat survived 5 days following ischaemia, giv-
ing a survival rate of 16.7%. All but one of the kinin-B1 re-
ceptor antagonist-treated animals died within the first
two days. n=6 for all groups, for the sham group: n=4.
The amylase levels in the ischaemia control group
(group II) rose to a maximum of 4454±986 U/l on the first
day after ischaemia, then decreased to 1711±658 U/l on
the fifth day following ischaemia. In the sham group
(group I) the levels were 1875±544 U/l on the first day
and 1683±725 U/l on the fifth.
The levels of blood glucose (106±13 mg/dl) remained
stable and were not affected by the sham operation or by
ischaemia/reperfusion. 
The number of peripheral leukocytes in the ischaemia/
reperfusion group (group II) increased from (12.4±3.5)×
1012 l– 1 cells/mm2 after ischaemia to (17.2±5.2)×1012 l– 1
cells/mm2 after five days of reperfusion. In the sham
group (group I) the numbers were (14.6±2.7)×1012 l– 1
cells/mm2 after sham operation and (12.2±5.2)×1012 l– 1
cells/mm2 after five days.
Carboxypeptidase M
Carboxypeptidase M activity, providing the appropriate
kinin-B1 receptor ligand, was elevated approximately
4-fold above control in ischaemic pancreatic tissue and
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Fig. 2 Acute Model: Haematocrit, Functional Capillary Density
and Adherent Leukocytes (see Material and Methods).
n=7 in each group; group 1: sham-operated, group 2: is-
chaemia/reperfusion control, group 3: kinin-B1 receptor antago-
nist, group 4: kinin-B1 and B2 receptor antagonists. Time points
show values at the end of preparation, end of ischaemia (2 h), af-
ter 30 min, 60 min and 120 min of reperfusion; values represent
mean ± SEM.
(A) Changes of haematocrit – during the reperfusion time the
haematocrit of the ischaemic groups rose, significantly for
group 2. *p<0.05 vs. sham-operated, kinin-B1 receptor antag-
onist and kinin-B1 and B2 receptor antagonists. **p<0.05 vs.
ischaemia/reperfusion control, kinin-B1 receptor antagonist
and kinin-B1 and B2 receptor antagonists (Student-Newman-
Keul test). (B) Functional capillary density (FCD), given as the
length of red blood cell-perfused capillaries per observation
area (cm/cm2), ischaemia/reperfusion injury induced signifi-
cantly capillary ‘no-reflow’ compared to the sham-operated
group and was worsened over time. *p<0.05 vs. ischaemia
control, kinin-B1 receptor antagonist and kinin-B1 and B2 re-
ceptor antagonists (Student-Newman-Keul test). (C) Number
of adherent leukocytes in at least 3 post-capillary venules. The
ischaemia/reperfusion control group showed a significant rise
in the count of stickers, antagonist-treated rats showed a
much lesser increase. *p<0.05 vs. sham, kinin-B1 receptor an-
tagonist and kinin-B1 and B2 receptor antagonists. **p<0.05
vs. sham-operated and ischaemia control (Student-Newman-
Keul test).
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10-fold in ischaemic and reperfused tissues. Figure 3
shows the mean ± SEM from three different experiments
in duplicate determinations.
Binding Studies and Receptor
Micro-Autoradiography
Receptor binding studies revealed changes in kinin-B1
receptor binding during ischaemia/reperfusion of rat
pancreas. Pancreatic cryosections were incubated as
described under Material and Methods. For ischaemic
tissue, kinin-B1 receptor binding was almost 16-fold
greater than the control value, and for pancreatic tissue
obtained from animals receiving 2 h reperfusion after 2 h
of ischaemia, the increase was 22-fold (Figure 4). For
kinin-B2 receptor binding, no significant changes were
observed (Figure 4).
High resolution receptor micro-autoradiography using
emulsion-coated coverslips, when displayed above the
cryosections of control tissue, showed only diffusely
scattered silver grains with no preference for any distinct
tissue structure (Figure 5A). On coverslips placed above
pancreatic tissue derived from ischaemic pancreas, the
arrangement of silver grains showed the beginning of
clustering (Figure 5B). The distribution of silver grains on
coverslips placed above ischaemia/reperfusion tissues
was restricted to acini. Dark clusters of silver grains rep-
resented specific [3H]des-Arg10-kallidin binding to dis-
tinct acini (Figure 5C).
Quantitation of [3H]des-Arg10-kallidin binding to rat
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Fig. 3 Carboxypeptidase M Up-Regulation.
Carboxypeptidase M activity was evaluated in tissue homo-
genates from control, ischaemic and ischemia/reperfusion rat
pancreas as described by Tan et al. (1995). Values represent
mean ± SEM of duplicate determinations. A massive increase of
carboxypeptidase M activity during ischaemia and ischaemia/
reperfusion processes could be evaluated.
Fig. 4 Kinin-B1 and B2 Receptor Binding Studies.
Pancreatic cryosections were obtained from the sham-operated
group, ischaemia group and ischaemia/reperfusion group. Sub-
sequent to association with a saturating concentration of [3H]
des-Arg10-kallidin (4 nM) or [3H] bradykinin (3.8 nM) in the pres-
ence (unspecific binding) or absence (total binding) of an excess
(1 µM) of unlabelled ligand (according to the method described
by Schremmer-Danninger et al., 1995), the binding reaction was
terminated. Sections were then wiped off with filter paper and
placed into scintillation vials for assessment of specific binding
that is calculated as the difference between total and unspecific
binding. Values represent mean ± SEM of triplicate determina-
tions. For kinin-B2 receptors, no significant changes in specific
binding were observed, whereas a dramatic rise in kinin-B1 re-
ceptor ligand binding could be demonstrated.
Fig. 5 Emulsion Micro-Autoradiographs of Kinin-B1 Recep-
tors on Pancreatic Lobes.
Incubation of pancreatic cryosections with [3H] des-Arg10-
Kallidin (4 nM) as described in Material and Methods. (A) Control:
Above cryosections of control tissue, receptor micro-autoradi-
ography using emulsion-coated coverslips displayed only dif-
fusely scattered silver grains with no preference for a distinct tis-
sue structure. (B) Ischaemia for 2 h: on coverslips above
pancreatic tissue derived from ischaemic pancreas the arrange-
ment of silver grains shows a beginning of clustering. (C) Is-
chaemia for 2 h and reperfusion for 2 h: the distribution of silver
grains above ischaemia/reperfusion tissues is restricted to acini.
Dark clusters of silver grains represent total [3H] des-Arg10-
Kallidin binding to distinct acini (*). (D) Histology (haematoxylin-
eosin) of a pancreatic lobe of control. Scale bar = 100 µM.
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pancreatic acinar cells on kinin-receptor micro-autoradi-
ographs, obtained by automated image analysis of silver
grain density above single acinar cells, showed an ap-
proximate 10-fold greater degree of binding for ischaemic
tissue, and a 17-fold greater binding to pancreatic tissue
subjected to 2 h of ischaemia and 2 h of reperfusion. This
quantitation of [3H]des-Arg10-kallidin is shown as an area
of particles in percent of total area predefined ± SEM and
revealed for pancreatic cryosections from the sham-op-
erated group 4.7±0.84, from the ischaemia group 46±2.8
and from the ischaemia/reperfusion group 78.2±3.5.
In Figure 5D, the staining with haematoxylin and eosin
illustrates the acinar areas of a pancreatic lobe of a sham-
operated rat. 
Specific Kinin-B1 Receptor Antibody
As demonstrated by receptor micro-autoradiography,
clusters of kinin-B1 receptors were located on acini. The
[3H]-labelled specific ligand bound specifically to acini in
pancreatic tissue with 2 h of ischaemia and 2 h of reper-
fusion. With the method of immunocytochemistry it could
be evaluated that at identical sites at which the specific
kinin-B1 receptor ligand bound, polyclonal anti-kinin-B1
receptor antibody also reacted with specific staining.
Method controls (replacement of primary antibody by
buffer or non-immune serum) and tissue controls (sham-
operated pancreas) did not reveal staining (not shown).
Discussion
A critical factor in the development and progressive
severity of acute pancreatitis is the degree of microcircu-
latory flow (Klar et al., 1990; Bassi et al., 1994). Failure in
nutritive perfusion causes focal hypoxia and cellular
damage, which in turn hinders reperfusion of the pancre-
atitis tissue. One reason for the reduction in microcircula-
tory flow during acute pancreatitis may be the local for-
mation of kinins by tissue and/or plasma kallikreins.
Kinins, by increasing the permeability of vessel wall, pro-
duce extensive oedema and damage to the pancreatic
cells (Griesbacher et al., 1993; Hirata et al., 2002). In
vessels with damaged endothelium, kinins act as vaso-
constrictors, thus further decreasing perfusion of the is-
chaemic areas (Pruneau et al., 1994). Both actions con-
tribute to a negative effect on microcirculation.
The cellular actions of kinins are mediated by two re-
ceptors, the kinin-B1 and B2 receptors. These receptors
activate cells through similar, but not identical, signalling
pathways (Marceau et al., 1997). They differ in tachyphy-
laxis (Austin et al., 1997), and the manner of expression.
In humans, although their gene sequences have a homol-
ogy of about 36% (Hall et al., 1997), they serve both sim-
ilar and contrasting functional responses (Regoli et al.,
1997), as observed in experiments involving the kinin-B1
and B2 receptor blockade. In a model of porcine endo-
toxin shock, the antagonism of kinin-B1 receptors pro-
duced functional effects opposite to those observed with
kinin-B2 receptor antagonists (Siebeck et al., 1996).
Kinin-B1, in contrast to B2 receptor antagonist, does not
inhibit the catecholamine production of neural cells, but
seems to have an agonistic effect similar to that of
bradykinin (Dendorfer et al., 1996). When endothelial le-
sions occur, the release of proteinases causes activation
of the coagulation cascade, which contributes to the fail-
ure of the microcirculation in acute pancreatitis. The acti-
vation of platelets, an important step in coagulation, is
also influenced by kinin-B1 receptor antagonism. Fur-
thermore, the application of a selective kinin-B2 receptor
antagonist was shown to have a protective effect on the
pancreas in different models of acute pancreatitis (Gries-
bacher et al., 1995; Kanbe et al., 1996; Asano et al., 1997;
Hoffmann et al., 1997; Bloechle et al., 1998). There was
an improvement in the microcirculation, less oedema, the
amylase levels within the pancreas were reduced, and
the survival rate increased. 
This study reports a novel action of the kinin-B1 recep-
tor antagonist in experimental pancreatitis. In the acute
model, microcirculatory parameters were assessed fol-
lowing 2 h of ischaemia and 2 h of reperfusion. The selec-
tive kinin-B1 receptor antagonist, as well as the combined
kinin-B1 and B2 receptor antagonists, decreased the
functional capillary density significantly. So, in contrast to
the selective kinin-B2 receptor antagonism, shown by
Hoffmann et al. (1996b,c), the nutritive perfusion of the
pancreas was reduced by the application of a kinin-B1 re-
ceptor antagonist. The post-ischaemic increase of the
adherent leukocytes, however, was reduced in all antago-
nist-treated groups. Usually the number of adherent
leukocytes is correlated with the degree of tissue damage
and with microcirculatory failure. The adhesion of numer-
ous leukocytes, mainly polymorphonuclear granulocytes,
to the endothelial cells of the post-capillary venules fur-
ther denotes the presence of inflammation. The release of
metabolites by activated leukocytes also contributes to
the ischaemia/reperfusion injury. In our study the leuko-
cyte-endothelium interaction seemed to be positively in-
fluenced by the kinin-B1 receptor antagonist, and in this
regard agrees with observations by Ahluwalia et al. (1996),
who have shown that the accumulation of polymorphonu-
clear leukocytes in air pouches of mice is inhibited by an-
tagonism of kinin-B1, but not the B2, receptors. The acti-
vation of polymorphonuclear leukocytes by kinin-B1
receptor ligand has also been reported (Carl et al., 1996).
Our experiments demonstrate that the application of
the kinin-B1 receptor antagonist, CP-0298, during is-
chaemically-induced pancreatitis aggravated the course
of acute pancreatitis. Moreover, in contrast to protective
effects observed by our group and others in previous
studies using only a kinin-B2 receptor antagonist, we ob-
served that the combined kinin B1 and B2 receptor an-
tagonists did not show any beneficial effects (Hoffmann
et al., 1996c; Kanbe et al., 1996). This deleterious effect
was independent of the significantly reduced leukocyte-
endothelium interaction.
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In our chronic model with five days of reperfusion, the
survival rate decreased drastically upon treatment with
the kinin-B1 receptor antagonist alone or in combination
with the kinin-B2 receptor antagonist. Versus the vehicle
treated group, a statistically significant difference in the
survival time could be seen. All but one animal died with-
in the first two days.
Furthermore, we included only animals that survived
the initial reperfusion period and completely awoke after
anaesthesia to minimize the variation caused by the ether
anaesthesia on the outcome. We observed that in the
kinin-B1 receptor antagonist treated animals, in addition
to the six animals included in the study, another seven
animals had to be excluded and in the combined treat-
ment group five animals died in the early resuscitation
period, whereas only one vehicle-treated animal had to
be excluded. Moreover, in the chronic model, animals
were observed for several days following the induction of
acute necrotizing pancreatitis without any pain medica-
tion or any form of anaesthesia. Therefore, as soon as
there were sufficient data to show that kinin-B1 antago-
nism would not benefit patients suffering from acute pan-
creatitis, either alone or in combination with kinin-B2 re-
ceptor antagonism, we stopped the experiments. It
should also be noted that several authors have described
a survival benefit of kinin-B2 receptor antagonism in
models of acute pancreatitis (Kanbe et al., 1996; Satake
et al., 1996; Yekebas et al., 2000). In our experiments the
combined antagonism of both kinin receptors not only
did not show any beneficial effects, but in fact decreased
the survival rate.
This up-regulation of kinin-B1 receptor along with in-
creased carboxypeptidase M activity in the ischaemic
and reperfused tissue may represent an important physi-
ological mechanism protecting from the damaging ef-
fects of pancreatic injury. Not only kinin-B2 receptor an-
tagonists, but also kinin-B1 receptor agonists, may be
protective in acute pancreatitis. Physiologically, car-
boxypeptidase M turns the kinin-B2 receptor ligand
bradykinin into an excellent kinin-B1 receptor agonist
that no longer exhibits high affinity for the kinin-B2 recep-
tor. The elevated activity of carboxypeptidase M leads to
an elevated amount of kinin-B1 receptor agonist. Up-reg-
ulation of kinin-B1 receptor can show its effects only if
enough specific agonist is available. 
Further studies are now necessary to clarify the molec-
ular mechanisms responsible for the detrimental effect of
the kinin-B1 receptor antagonist.
Materials and Methods
Acute Model
The current study was designed using the recently described is-
chaemia/reperfusion model of acute pancreatitis (Hoffman et al.,
1995) with minor modifications. The experiments were per-
formed on 35 male Sprague-Dawley rats (Charles River, Sulz-
feld, Germany), weighing 180 – 250 g. Anaesthesia was induced
by ether inhalation following intraperitoneal application of chlo-
ralhydrate (250 mg/kg body weight, i.p. as bolus injection) and
maintained by intravenous infusion of α-chloralose (approxi-
mately 20 mg/kg body weight per hour, i.v.). The rats were
placed on a heating plate and body temperature was kept at
36.5°C (± 0.5°C). After tracheotomy, the animals were mechan-
ically ventilated (arterial pO2: 100 – 110 mm Hg, arterial pCO2:
35 – 40 mm Hg). Polyethylene catheters (PE50, 0.58 ID, 0.96 OD,
Portex, Hythe, Kent, UK) were placed into the right common
carotid artery and jugular vein and connected to pressure trans-
ducers. The abdomen was transversely opened, the short gas-
tric arteries ligated and dissected, and the greater omentum re-
moved from the greater curvature of the stomach. Once the
surgical preparation was completed, the animals were allowed
to stabilise for 30 min. To create complete and reversible is-
chaemia of the pancreas, the four supplying arteries (gastroduo-
denal artery, left artery, splenic artery and caudal pancreatico-
duodenal artery) were occluded with microvascular clips
(Aesculap-Yasargil-Standard-Aneurysm-Clip Temporary, cat.
no. FE 751 K, closing force 70 g, Aesculap, Tuttlingen, Ger-
many). After 2 h of ischaemia, the clips were removed and the
pancreas in situ carefully positioned on a stage for quantitative
analysis of microcirculation, including functional capillary densi-
ty and leukocyte-endothelium interaction by intravital fluores-
cence microscopy. Fifteen minutes before onset of reperfusion
the continuous infusion of the respective drug was started. The
osmotic minipump (Alzet Model 2001, Alza Corporation, Palo
Alto, USA) was filled with phosphate buffer (0.01 M, pH 7.4) or
antagonists (dissolved in phosphate buffer) (antagonists provid-
ed by Cortech, Inc., Denver, USA) and placed intraperitoneally.
Tissue samples from the body of the pancreas were taken 2.5 h
after onset of reperfusion and after fixation stained with haema-
toxylin and eosin for histological examination.
The macro-haemodynamic parameters, mean arterial pres-
sure (MAP), heart rate (HR) and central venous pressure (CVP),
were monitored continuously during the entire experiment. The
systemic haematocrit was assessed at the beginning and at the
end of each experiment, and also at the end of ischaemia. At the
beginning and at the end of the experiment, the peripheral
leukocyte cell count was determined using a Coulter Counter
T540 (Coulter Electronics, Hialeah, USA). 
The experimental protocol for the acute study comprises four
groups of seven animals in each group (n=7):
Group 1: sham. Animals underwent sham operation without
vessel occlusion, the osmotic minipump was filled with (0.9%
v/v) sodium saline solution. The animals received 2 ml/h.
Group 2: ischaemia/reperfusion control. Rats received 2 h of
ischaemia and infusion (2 ml/h) of phosphate buffer.
Group 3: kinin-B1 receptor antagonist. Animals received 2 h of
ischaemia and infusion (2 ml/h) of the selective kinin-B1 receptor
antagonist CP-0298 at a concentration of 18 µg kg– 1 h– 1 dis-
solved in phosphate buffer.
Group 4: kinin-B1 and B2 receptor antagonists. Rats received
2 h of ischaemia and infusion (2 ml/h each) of CP-0298 (18 µg
kg– 1 h– 1), a selective kinin-B1 receptor antagonist and CP-0597
(18 µg kg– 1 h– 1), a selective kinin-B2 receptor antagonist, given
by two different minipumps.
Animals with any sign of pancreatic oedema or haemorrhage,
or a mean arterial blood pressure of less than 90 mm Hg at the
beginning of ischaemia, e.g. with signs of tissue damage or sys-
temic stress caused by the preparation, were immediately sacri-
ficed. Animals, that did not survive 2.5 h reperfusion are listed in
the results section, but were not counted toward the seven ani-
mals per group.
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Microcirculatory Studies
The microcirculation was assessed by intravital microscopy at
30 min, 60 min and 120 min after inset of reperfusion. To enhance
the contrast of the microvessels, 0.1 ml of 0.75% (v/w) fluorescein
isothiocyanate-labelled hydroxyethyl starch (FITC-HAES, Laevo-
san, Linz, Austria) was intravenously injected before each period
of microscopy. Leukocytes were stained in vivo by intravenous
application of 0.1 ml 0.2% (v/w) rhodamine 6G (Sigma, St. Louis,
USA). A saltwater immersion objective (SW 25/0.60, Leitz, Wet-
zlar, Germany) was used to achieve a magnification of about 800-
fold. For off-line evaluation, images were stored on videotape
(video recorder AG-7330, Panasonic, Munich, Germany).
The functional capillary density (FCD) of the pancreas was as-
sessed after injection of FITC-HAES in ten randomly selected ar-
eas. It is defined as the length (cm) of erythrocyte-perfused cap-
illaries per observation area (cm2). Following the method
described by Schmid-Schoenbein et al. (1977), the number of in-
tersections between perfused capillaries and a grid system su-
perimposed on a video screen was counted and the capillary
length per observation area calculated.
The leukocyte-endothelial interaction was evaluated in three
selected post-capillary venules with a diameter of 15 to 40 µm
and more than 100 µm length. Non-adherent leukocytes were
defined as cells freely flowing within the blood stream, with no
interaction with the endothelium during the 30 s of observation
period. Rolling leukocytes were defined as cells intermittently in-
teracting with the endothelium for less than 30 s. Adherent
leukocytes (stickers) were defined as leukocytes attached to the
inner vessel surface for the entire observation period of 30 s, and
are expressed as the number of cells per endothelial surface
area (mm2). The surface area was calculated assuming a cylin-
drical geometry of the vessel using diameter and length of the
observed segment. The leukocyte flux was determined as the
number of leukocytes passing the segment per second.
Chronic Model with Five-Day Reperfusion
Twenty-two male Sprague-Dawley rats (body weight 180 – 240 g)
were used. Surgical anaesthesia was induced and maintained
with vapourised ether inhaled by the spontaneously breathing
animals. For volume replacement (3 ml 0.9% NaCl/h), and for
taking blood samples the right jugular vein was canulated with
polyethylene tubes. After medial laparotomy and ligation of the
short gastric arteries, the four supplying arteries of the pancreas
were prepared and occluded for 2 h using microvascular clips.
After 105 min (15 min before onset of reperfusion) one or two os-
motic minipumps (Alzet Model 2001, Alza Corporation) filled with
the respective drug were placed into the lower abdomen, and
continuous perfusion (1.06 µl/h) of the peritoneum commenced.
After removing the microvascular clips, the abdomen was closed
by a trilaminar suture. The catheter was led subcutaneously to
the neck and between the ears through the skin. It was fixed by a
tobacco bag and raised three centimetres above skin level using
a titan clip (Endo Clip II MI, Auto Suture, Tönisvorst, Sweden).
The ether inhalation was stopped, and when the animals gained
consciousness they were given free access to water and food.
Each day, after 2 h of fasting, blood samples (0.6 ml) were taken
to assess the serum pancreatic amylase levels, using the P-amyl
MPR 2 test (Boehringer, Mannheim, Germany) and fasting blood
sugar levels. After five days of reperfusion the animals were killed
by infusion of KCl through the catheter.
The experimental protocol for the chronic study comprised
four to six animals in each group (antagonists provided by
Cortech, Inc., Denver, USA).
Group I: sham (n=4). Animals were sham-operated and their
abdomens left open for 2 h.
Group II: ischaemia/reperfusion control (n=6). Animals under-
went 2 h of ischaemia, 15 min before the end of ischaemia a
minipump, filled with phosphate buffered saline, was placed into
their abdomens and release was started.
Group III: kinin-B1 receptor antagonist (n=6). Rats received
2 h of ischemia and infusion of CP-0298 (18 µg kg– 1 h– 1).
Group IV: combined kinin-B2 and B1 receptor antagonists
(n=6). Rats received 2 h of ischaemia and infusion of CP-0298
(18 µg kg– 1 h– 1) and CP-0597 (18 µg kg– 1 h– 1).
Receptor Binding Studies
For receptor binding studies and autoradiographic staining of the
kinin receptors the pancreas was removed before ischaemia (con-
trol group), after 2 h of ischaemia (ischaemia group), and after 2 h
of ischemia and 2 h of reperfusion (ischaemia/reperfusion group).
Tissue was washed in phosphate buffered saline (0.01 M, pH 7.4)
and immediately frozen in liquid nitrogen and stored at – 80°C.
Cryosections were incubated, according to the method de-
scribed by Schremmer-Danninger et al. (1995) for 2 h in an ice
bath in 25 mM TES buffer (pH 6.8) sucrose 300 mM, BSA 2%,
DTT 1 mM, supplemented with a protease inhibitor mixture con-
sisting of bacitracin 2 mM, 1.10-phenanthroline 1 µM, captopril
10 µM, phosphoramidon 10 µM. In kinin-B2 receptor studies
4.5 nM Mergetpa, a specific carboxypeptidase M inhibitor, was
included in the protease inhibitor mixture. Binding studies were
carried out by addition of nearly saturating concentrations of
3.8 nM [3H]bradykinin (specific activity: 108 Ci/mmol) or 4 nM
[3H]des-Arg10-kallidin (specific activity: 98 Ci/mmol) as kinin-B2
and B1 receptor agonists in the presence (non-specific binding)
or absence (total binding) of 1 µM unlabelled agonist. Incuba-
tions were terminated by washing the cryosections twice in TES
buffer (25 mM, pH 6.8) including inhibitors to remove excess of
free radioligand and finally dipped for one time in distilled water
to remove salts. Sections were then immediately wiped off with
filter paper and placed into liquid scintillation vials. After addition
of 15 ml of scintillation fluid (Quickscint 212, Zinsser Analytic,
Frankfurt, Germany), [3H] radioactivity was assessed in a Beck-
man β-scintillation counter. Specific binding was calculated as
the difference between total and non-specific binding.
Receptor Autoradiography 
High-resolution receptor micro-autoradiography was carried out
as described by Schremmer-Danninger et al. (1995). For visuali-
sation of ligand binding on cryostat section processed tissue,
sections were dried and vapour fixed with paraformaldehyde
(2 h, 80°C), defatted and exposed to emulsion coated cover
slips for approximately 8 weeks. Developed emulsion-autoradi-
ographs were scanned by a TV camera (Bosch TVK 920, Plumbi-
con, Darmstadt, Germany) and digitised in the frame grabber
Matrox MVP-AT/NP of the PC-based image analyser SAMBA
(TITN, Grenoble, France). Areas of interest were selected inter-
actively by the examiner and after definition of the threshold, dif-
ferent parameters were evaluated. The system assessed the
number of pixels corresponding to a selected area on the level of
the cryostat section. The area of the particle was quantified, and
the area of all the particles within the predefined area was given
as a percent of the total area.
Carboxypeptidase M Assay
Carboxypeptidase M activity was evaluated according to the
method of Tan et al. (1995). The enzyme activity was evaluated in
duplicate determinations in tissue homogenates from control, is-
chaemic and ischaemia/reperfusion rat pancreas. The mean ±
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SEM of three representative experiments is shown. The assay is
based on the fluorescent substrate dansyl-Ala-Arg, and utilises
the ability to extract the product, dansyl-Ala, into chloroform
while the remaining substrate stays in the aqueous phase at acid
pH. The fluorescence was measured at 340 nm excitation wave-
length and 495 nm emission.
Immunocytochemistry
Immunoperoxidase Slides with tissue sections were placed
on a heating mantle until the wax melted, and then dewaxed in
xylene. Tissues were rehydrated through a series of increasingly
dilute ethanol solutions, and placed in distilled water as the final
rehydrant. Between the 90% and 70% ethanol hydration steps,
tissue has to be immersed in absolute methanol for 25 min to
quench endogenous peroxidase activity. Moderate boiling in
0.01 M Na-citrate buffer (pH 6.0) for 2 min in a microwave oven at
80°C follows for fixation. Then the tissue is allowed to cool to
room temperature (RT) and placed again in distilled water. Be-
fore incubating in 10% H2O2/95% methanol (v/v) for 20 min at RT
to quench endogenous peroxidases a second time, the tissue
has to be washed one time in 0.01 M phosphate buffered saline
(pH 7.4)/1% bovine serum albumin (v/v) to reduce non-specific
binding and afterward two times in 0.01 M phosphate buffered
saline (pH 7.4). The incubation with the first antibody, diluted in
maleic acid/10% milk-blocker in PBS (Boehringer), takes place
overnight at 4°C in a humidified chamber. After two washing
steps with 0.01 M phosphate buffered saline (pH 7.4) the tissue
on the slides is treated with the peroxidase-anti-peroxiodase
(PAP) streptavidin-biotin conjugated system (LSAB K0690,
DAKO, Hamburg, Germany) for 20 min each, with phosphate
buffered saline (pH 7.4) wash steps in between. The labelled an-
tibody bound to the PAP immuno-enzyme complex is visualised
by incubating the liquid diaminobenzidine (DAB) precipitant
(K3468, DAKO) up to 4 min in the dark. Tissue is counterstained
with Mayer’s haematoxylin and eosin. Then the tissue is washed
in tap water for 5 min, dehydrated through an ethanol series in
xylene and mounted in Entellan (Merck, Ismaning, Germany).
Results were viewed by conventional light microscopy.
Immunolabelling Controls In order to assess the specificity
of the immunolabelling, method, controls were performed in
which the primary antibody was replaced by either buffer (PBS)
or non-immune serum. 
Anti-Kinin-B1 Receptor Antibody This antibody was kindly
provided by Prof. Müller-Esterl and is a mixture of antibodies
(AS 367 – 75) directed to various specific sequences of the hu-
man B1 receptor raised in rabbits, and was used at a dilution of
1/800. This antibody also reacts specifically with murine tissue
as the genomic sequences of human, mouse, rabbit and canine
kinin B1 receptors show homology that varies from 72 – 76%
(Hess et al., 1996). As secondary antibody the appropriate anti-
species antibody IgG was used as the sandwich antibody.
Statistics
All data are shown as mean ± SEM. Friedman analysis of vari-
ance in ranks and Student-Newman-Keul Test were used to
show significant differences between the groups. Differences
were considered significant at p<0.05.
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